Open framework agreement on pharmaceutical discount agreements, open accession (approval model 2026-08)
Lot 32 (testosterone 16.2 mg per sachet, gel) has been withdrawn with immediate effect in a change to the original publication of 17 June 2026 (416394-2026).
The page shows the accession deadline of 5 June 2028 at 23:59 (UTC+02:00), the time stated in the official TED notice 704317-2026.
TED Europa (Tenders Electronic Daily)
Overview
Deutsche Rentenversicherung Knappschaft-Bahn-See (KBS) invites pharmaceutical companies to join its discount agreements under section 130a(8) SGB V for 41 lots, each covering one active substance or dosage form. Joining is possible at any time until the accession deadline of 5 June 2028 at 23:59 (UTC+02:00). The authority states that this is not an open procedure under section 15 VgV in conjunction with section 119(3) GWB, but an invitation to accede to terms that are fixed for all participants and not negotiable, including the discount rate. Each lot runs from 1 August 2026 to 31 July 2028. Companies accede with signed declarations and the contract, sent by post or, with a qualified electronic signature, by email. Lot 32 has been withdrawn.
Information based on the public notice
Ask about this tender
What the buyer needs
KBS invites pharmaceutical companies to accede to discount agreements under section 130a(8) SGB V for 41 lots, each tied to a specific active substance and dosage form. Lot 32 has been withdrawn. The authority describes the publication as an invitation to accede to contracts whose conditions, including the discount rate, are set for all participants and are not negotiable. Any number of eligible companies may join, so the scope is open-ended until the accession deadline.
- Only pharmaceutical companies, or working groups of pharmaceutical companies within the meaning of section 4(18) AMG, are invited to participate.
- Declaration that no exclusion grounds under sections 123 and 124 GWB apply (Anlage 3).
- Declaration of the marketing authorisation under section 21(1) AMG (Anlage 4).
- Simple extract from the commercial register, or comparable proof, not older than six months at the start of the contract term.
- Declaration on the EU sanctions package against Russia (Anlage 5).
- Documents signed by hand and sent by post, or carrying a qualified electronic signature and sent by email to the functional address.
Lots
LOT-0001 ·Buprenorphin, Naloxon, Darreichungsform: SUT (ATC-Code: N07BC51)
LOT-0002 ·Dienogest, Estradiol (ATC-Code: G03FA15)
LOT-0003 ·Dorzolamid, Darreichungsform: ATR - Einzeldosispipetten (ATC-Code: S01EC03)
LOT-0004 ·Escitalopram, Darreichungsform: TEI (ATC-Code: N06AB10)
LOT-0005 ·Pregabalin, Darreichungsform: LSE (ATC-Code: N02BF02)
LOT-0006 ·Promethazin, Darreichungsform: TEI (ATC-Code: R06AD02)
LOT-0007 ·Testosteron, Darreichungsform: ILO (ATC-Code: G03BA03)
LOT-0008 ·Clobetasol 17-propionat (ATC-Code: D07AD01)
LOT-0009 ·Doravirin (ATC-Code: J05AG06)
LOT-0010 ·Ethosuximid, Darreichungsform: WKA (ATC-Code: N03AD01)
LOT-0011 ·Mercaptopurin, Darreichungsform: SUE (ATC-Code: L01BB02)
LOT-0012 ·Mercaptopurin, Darreichungsform: TAB (ATC-Code: L01BB02)
LOT-0013 ·Pimecrolimus, Normgröße N1, Darreichungsform: CRE (ATC-Code: D11AH02)
LOT-0014 ·Everolimus, Darreichungsform: TAB (ATC-Code: L01EG02)
LOT-0015 ·Lisdexamfetamin, Darreichungsform: HKP (ATC-Code: N06BA12)
LOT-0016 ·Morphin, Darreichungsform: FTA, HKP (ATC-Code: N02AA01)
LOT-0017 ·Poly(styrol-co-divinylbenzol)sulfonsäure (ATC-Code: V03AE01)
LOT-0018 ·Safinamid (ATC-Code: N04BD03)
LOT-0019 ·Prednicarbat, Darreichungsform: CRE (ATC-Code: D07AC18)
LOT-0020 ·Prednicarbat, Darreichungsform: SAL (ATC-Code: D07AC18)
LOT-0021 ·Prednicarbat, Darreichungsform: LOE (ATC-Code: D07AC18)
LOT-0022 ·Prednicarbat, Darreichungsform: FET (ATC-Code: D07AC18)
LOT-0023 ·Pivmecillinam, Darreichungsform: FTA (ATC-Code: J01CA08)
LOT-0024 ·Prednisolon, Darreichungsform: ATR (ATC-Code: S01BA04)
LOT-0025 ·Treprostinil, Darreichungsform: INF (ATC-Code: B01AC21)
LOT-0026 ·Dihydrocodein, Darreichungsform: TEI (ATC-Code: N02AA08)
LOT-0027 ·Dexamethason, Gentamicin, Darreichungsform: ATR (ATC-Code: S01CA01)
LOT-0028 ·Dexamethason, Gentamicin, Darreichungsform: AUS (ATC-Code: S01CA01)
LOT-0029 ·Dexamethason, Gentamicin, Darreichungsform: KPG (ATC-Code: S01CA01)
LOT-0030 ·Levodopa, Carbidopa, Darreichungsform: RET (ATC-Code: N04BA10)
LOT-0031 ·Levodopa, Benserazid, Darreichungsform: REK (ATC-Code: N04BBA11)
LOT-0032 ·Testosteron 16,2mg je Beutel, Darreichungsform: GEL (ATC-Code: G03BA03)
LOT-0033 ·Testosteron 20mg je Beutel, Darreichungsform: GEL (ATC-Code: G03BA03)
LOT-0034 ·Testosteron 50mg je Beutel, Darreichungsform: GEL (ATC-Code: G03BA03)
LOT-0035 ·Metronidazol, Darreichungsform: GEL (ATC-Code: D06BX01)
LOT-0036 ·Dexamethason, Darreichungsform: IMP (ATC-Code: S01BA01)
LOT-0037 ·Brimonidin, Darreichungsform: EDP (ATC-Code: S01EA05)
LOT-0038 ·Chinin (ATC-Code: P01BC01)
LOT-0039 ·Chlortalidon (ATC-Code: C03BA04)
LOT-0040 ·Codein, Darreichungsform: TAB (ATC-Code: R05DA04)
LOT-0041 ·Pimecrolimus, Normgröße N3, Darreichungsform: CRE (ATC-Code: D11AH02)
Tender details
- Buyer
- Deutsche Rentenversicherung Knappschaft-Bahn-See, Dez. IX.1.1 Vergabestelle, Bochum
- Country
Germany
- Procedure
- Open framework agreement with open accession under section 130a(8) SGB V (not an open procedure under section 15 VgV)
- Classification
- Pharmaceuticals and laboratory supplies · CPV 33600000
- Notice reference
- 704317-2026
- Subject
- Pharmaceutical discount agreements for 41 lots (lot 32 withdrawn); CPV 33600000
- Place of performance
- Nationwide in Germany
- Accession deadline
- 5 June 2028, 23:59 (UTC+02:00)
- Contract term per lot
- 1 August 2026 to 31 July 2028
- Submission of documents
- Signed declarations and contract by post, or with a qualified electronic signature by email to the functional address in the notice
What to check in the tender documents
- The notice text does not state the discount rates, which the authority says are fixed in the contract terms.
- The notice does not state an estimated value or expected volumes.
- The contract documents are requested from KBS by email and are not summarised here.
Original notice
Read the original description
Offene Rahmenvereinbarung über Arzneimittelrabatte gemäß § 130a Abs.8 SGB V mit jederzeitiger Beitrittsmöglichkeit, sog. Zulassungsmodell 2026-08
Official source: TED Europa (Tenders Electronic Daily) ↗
https://ted.europa.eu/en/notice/-/detail/704317-2026
Source retrieved: 2026-11-12T03:43:49Z